Clinical Trials Logo

Clinical Trial Summary

The aim of the suggested study is to assess the added value of 68Ga-FAPI-04 PET/CT over 18F-FDG PET/CT in evaluating the extent of disease in patients with various malignancies, in whom a diagnostic challenge is met, such as inconclusive findings on 18F-FDG PET/CT or other imaging studies, better delineation of tumor extent prior to therapy, and with emphasis on malignancies known to show variable avidity to FDG and at times, no uptake at all. Also patients unable to optimally comply with the required preparation for FDG imaging, such as diabetic patients who struggle in achieving glycemic control.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04441606
Study type Interventional
Source Tel-Aviv Sourasky Medical Center
Contact IRA DANA
Phone +97236974373
Email irako@tlvmc.gov.il
Status Recruiting
Phase N/A
Start date June 11, 2020
Completion date July 2021